Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake

Page 7 of 10

Page 7 of 10 – SEC Filing
CUSIP NO.
867328502
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
[ ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
[ ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
[ ]
Insurance Company as defined in Section 3(a)(19) of the Act
(d)
[ ]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[ ]
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)
[ ]
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)
[ ]
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
[ ]
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
[ ]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[ ]
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
(k)
[ ]
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
Item 4. Ownership***
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount Beneficially Owned***
Cormorant Global Healthcare Master Fund, LP – 831,500 shares
Cormorant Global Healthcare GP, LLC – 831,500 shares
Cormorant Asset Management, LLC – 1,000,000 shares
Bihua Chen – 1,000,000 shares
(b)
Percent of Class
Cormorant Global Healthcare Master Fund, LP – 4.28%
Cormorant Global Healthcare GP, LLC – 4.28%
Cormorant Asset Management, LLC – 5.14%
Bihua Chen – 5.14%
(c)
Number of shares as to which such person has:
(i)
sole power to vote or to direct the vote
Cormorant Global Healthcare Master Fund, LP – 0 shares
Cormorant Global Healthcare GP, LLC – 0 shares
Cormorant Asset Management, LLC – 0 shares

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 7 of 10